Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAS-1 Adjuvanted vs Unadjuvanted Influenza Vaccines in the Elderly
NCT01623232Phase 2Withdrawn
- Sponsor
- United States Department of Veterans Affairs
- Start
- Oct 2012
- Primary completion
- Nov 2013
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of MAS-1 in influenza, sponsored by United States Department of Veterans Affairs. Planned start Oct 2012; status: withdrawn.
02
Drugs
MAS-1
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01623232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01623232.